STME
vs
S&P 500
STME
S&P 500
Over the past 12 months, STME has significantly outperformed S&P 500, delivering a return of +148% compared to the S&P 500's +15% growth.
Stocks Performance
STME vs S&P 500
Performance Gap
STME vs S&P 500
Performance By Year
STME vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
StimCell Enegetics Inc
Glance View
StimCell Enegetics Inc is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-03-11. StimCell Enegetics Inc., formerly Cell MedX Corp., is a development stage electroceutical medical device company. The Company’s products include eBalance, and Bio Feedback. The eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms. The biofeedback mechanism is where eBalance offering users and health professionals alike a real-time snapshot of cellular vitality. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling. Microcurrent is a clinically tested therapy treatment used to treat a range of conditions. There is compelling research in diabetes care, wound therapy, migraine treatment, chronic obstructive pulmonary disease (COPD), and anti-ageing.
